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For Dissertation submitted to Tamilnadu Dr.M.G.R Medical University 
University registration number : 201325053 
ABSTRACT 
Title: Prevalence and factors associated with Gestational Diabetes Mellitus among 
antenatal women attending a rural health center in Vellore 
Background: Gestational Diabetes Mellitus is one of the significant causes of maternal 
and fetal morbidity. The prevalence of GDM is low in western world and high in South 
East Asia. The prevalence in India varies according to the criteria used and the population 
studied.  
Objective: 1) To estimate the prevalence of Gestational Diabetes Mellitus 
(GDM) among antenatal women attending a Rural health Centre attached to  
Christian Medical College, Vellore.2) To study the associations between 
anthropometry, parental history, physical activity of pregnant women and 
GDM. 3) To compare the dietary energy intake of antenatal women with  and 
without Gestational Diabetes Mellitus.  
 
Methods:  A hospital based cross sectional study among pregnant women. 630 women 
recruited for OGTT. GDM diagnosed as per IADPSG criteria at 24 to 28 weeks. Among 
563 who underwent OGTT all 75 GDM women and subset of women without GDM 
selected randomly and were visited at their homes. The study tool used was semi 
structured questionnaire; PPAQ (pregnancy physical activity questionnaire), 24 hrs 
dietary recall, and skin fold thickness measurements. 
Results and conclusions: The hospital based prevalence of GDM was 14% (95 % CI: 
11.3% to 16.7%). Women with family history of DM had 2.65 times risk of GDM  
adjusted OR 2.65(1.34 to 5.25) , women with body fat of more than 23% 2.89 times risk 
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of GDM adjusted OR 2.89(1.47 to 5.68). The age specific prevalence showed an 
increasing trend.chi square of trends=15.186(p<0.001) 
It was concluded from the study that universal screening of GDM is needed. In primary 
and secondary care settings where universal screening is not done selective screening to 
include early pregnancy BMI and body fat percentage. 
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1. Introduction 
Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance 
with onset or recognition of high blood glucose levels during pregnancy (1).   
The diagnosis of GDM during pregnancy is by estimation of blood glucose levels. 
The current diagnostic criteria of International Association of Diabetes and Pregnancy 
Study Group (IADPSG) 2008 were based on an international study called Hyperglycaemia 
and Adverse Pregnancy Outcomes (HAPO). The diagnosis of GDM made by current 
IADPSG criteria could pick up even milder forms of GDM when compared to previous 
criteria laid down by World Health Organization (WHO).The WHO criteria introduced in 
1980s for diagnosis of GDM had a cut off of fasting glucose ≥7.0 mmol/l and 75 gram 2 
hr Oral Glucose Tolerance Test OGTT ≥ 7.8 mmol/l (2).  
 
The prevalence of GDM is less in western countries when compared with 
Mediterranean and South East Asian countries. The prevalence of GDM in 
Canadian population is 2.5% (3). Studies from the Middle East like Saudi 
Arabia have documented the prevalence of GDM to be 12.5%(4).The prevalence 
of GDM in India varies between regions. From a study done at Haryana , the 
hospital based prevalence of GDM was 7.1%(5).The prevalence in a hospital at 
Lucknow, Uttar Pradesh was 41.9%(6).The prevalence of GDM in Tamilnadu 
from a community based study done at Chennai was 17.8%in urban,13.8%in 
semi urban and 9.9% in rural areas of Tamilnadu (7).  In a study in southern part 
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of Tamilnadu at Trichirapalli, the prevalence of GDM in a tertiary hospital was 
23% (8). 
The consequences of GDM affect both the mother and foetus. Gestational 
diabetes Mellitus is one among various causes during pregnancy that can lead 
to poor outcomes of pregnancy which include macrosomia, pre term birth, still 
birth, shoulder dystocia, congenital malformations, hypoglycaemia of the new 
born and unexplained foetal deaths. Maternal outcomes include poor glycemic 
control during pregnancy, susceptibility to infections, cephalo-pelvic 
disproportion, operative deliveries , type II diabetes in later life (3, 9, 10) 
 Studies show that GDM if treated resulted in significant decline in the relative risks of 
occurrence of Macrosomia (RR = 0.47), large for gestational age (RR = 0.57), shoulder 
dystocia (RR = 0.41).Also the risk of perinatal mortality, admissions to neonatal intensive 
care units (NICU), trauma at birth was reduced (11). Proper and expected management 
would result in decrease of poor perinatal, maternal and neonatal outcomes, decrease 
admission of newborns to ICUs and decrease hospital stay (12).  
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2. Justification 
Before the findings of the HAPO study became available, selective screening was in 
practice to detect GDM among pregnant women. However, after the HAPO study results 
there was a paradigm shift in the approach to diagnose GDM, as the HAPO study showed 
that high glycemic levels lower than the then existing standard cut off levels prescribed by 
WHO led to significant complications in the perinatal period. Based on the HAPO study, 
the IADPSG guidelines recommends universal screening of pregnant women for GDM. 
The screening is a two-step process. The first step is estimation of fasting blood glucose 
levels in early pregnancy, followed by 75 gram 2 hr OGTT at 24 to 28 weeks for women 
who test normal in the initial screening.  
The Indian guidelines issued by government approved Diabetes In Pregnancy Study 
Group India (DIPSI)for screening and diagnosis of GDM recommends 2 hr blood glucose 
estimation by Glucose Oxidase-Peroxidase method (GOD - POD) after administration of 
75 grams of glucose(13). The cut of ≥140 mg/dl is considered as both screening and 
diagnosis of GDM. The advantages are that pregnant woman need not be in a fasting state 
at the time of the test and the possibility of drop out from antenatal visit is less. 
The State Health System in Tamilnadu practices universal screening of pregnant women at 
12 to 16 weeks, 24 to 28 weeks, and 32 to 34 weeks by doing 75 grams 2 hrs OGTT (14). 
In Primary Health Centres where lab technicians are not available nurses are trained to do 
the test using a semi auto analyser. But although guidelines exist, if the equipment is not 
functioning at the centre fasting and random blood glucose by Glucometer is done to check 
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glucose levels (14). The private health care sector in Tamilnadu follows the screening 
procedures according to the treating doctor’s preference of the investigation. Most 
commonly 75 grams OGTT at 24 to 28 weeks is done as most private Obstetricians follow 
Federation of Obstetrics and Gynaecology Society of India guidelines (FOGSI). 
 
The Obstetrics and Gynaecology department of  Christian Medical College, 
Vellore follows the IADPSG guidelines of universal screening of pregnant 
women by a two-step process. The detailed method of screening is given in the 
forth coming sections. 
 
The Rural Health Centre attached to Christian medical college, Vellore is run 
by the Department of Community Health through its 110 bed Community health 
and Development (CHAD) Hospital. The hospital had been doing high risk 
screening among antenatal women to detect GDM.OGTT was performed only 
on women who had significant family history of diabetes, previous bad obstetric 
history or high risk pregnancy. The people attending CHAD hospital are from 
Kaniyambadi block and also from neighbouring towns of Polur, Arni and 
Ranipet. Hence a hospital based study to estimate the prevalence and 
determinants of GDM among the ante natal women attending the  Rural Health 
Centre would help in reducing the maternal morbidity, perinatal mortality and 
morbidity among antenatal women seeking health care in CHAD hospital. This 
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would also help with prevention and management of GDM during pregnancy, 
childbirth and in later life. 
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3. Objectives 
 
 
1) To estimate the prevalence of Gestational Diabetes Mellitus (GDM) among 
antenatal women attending a Rural Health Centre attached to Christian Medical 
College, Vellore. 
 
2) To study associations between       
a)  Nutritional anthropometry of pregnant women and Gestational Diabetes 
Mellitus.      
b) Parental diabetic status and Gestational Diabetes Mellitus.        
c) Physical activity patterns and Gestational Diabetes Mellitus.  
 
3) To compare the dietary energy intake of antenatal women with and without 
Gestational Diabetes Mellitus.  
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4. Literature review 
 
4.1 Definition of Gestational Diabetes Mellitus:  
Gestational diabetes is defined as ‘carbohydrate intolerance resulting in 
hyperglycaemia of variable severity with onset or first recognition during 
pregnancy’ (1).There lays a possibility that unrecognized intolerance to glucose 
present before pregnancy would also be diagnosed as GDM. This definition is 
accepted standard definition used in the medical world (1). 
 
4.2 Prevalence of Type II Diabetes Mellitus: 
The WHO has documented the global prevalence of Diabetes Mellitus (DM) Type II of the 
year 2012 among adults 18 years of age and above to be 9%(15).More than 80% of Diabetic 
deaths occur in low and middle income countries(15). The following Figure4.1 illustrates 
the prevalence of Diabetes mellitus for the year 2013.India has a prevalence of Type II 
Diabetes Mellitus above 18 years of age from 9% to 12%. The number of people with 
Diabetes Mellitus  above 18 yrs of age in the year 2000 was 31,705,000 and the estimate 
for the year 2030 is 79,441,000(15). 
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4.3 Prevalence of GDM: 
The prevalence of GDM varies between countr ies and between ethnic groups. 
The prevalence of GDM is 2.5% in Canadian population (3). Studies from 
Middle East like Saudi Arabia showed prevalence of GDM to be of 12.5% (4). 
The hospital based prevalence of GDM in India varies between regions. The 
prevalence of DM Type II in various countries is shown by Figure: 4.1.  From a 
study done at Haryana the hospital based prevalence of GDM was 7.1% (5) .The 
prevalence in a hospital at Lucknow, Uttar Pradesh was 41.9% (6).In a study in 
southern part of Tamilnadu at Trichirapalli, the hospital prevalence of GDM 
was 23%(8).The community based prevalence of GDM in Tamilnadu study done 
at Chennai was 17.8%in urban, 13.8%in semi urban and 9.9% in rural areas of 
Tamilnadu (7). 
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Figure: 4.1: Prevalence of Diabetes Mellitus Type II in the world 2013 
 
  
 
4.4 Diabetes Mellitus before pregnancy: 
Women known to have Diabetes Mellitus before onset of pregnancy are termed as 
‘Diabetes Mellitus and pregnancy’ and not as GDM (1). The presence of Diabetes before 
pregnancy could be Type I Diabetes Mellitus. Those with Type I Diabetes would have high 
Source: International 
Diabetic Foundation 
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glucose levels and it has to be detected in early pregnancy. The various methods of 
screening available are discussed in forth coming sections. 
 
4.5 Pathophysiology of GDM: 
 Figure 4.2 Pathophysiology of GDM and insulin resistance               
         
     
  
Earlier studies done on pathophysiology of Gestational Diabetes have demonstrated the 
presence of islet cell antibodies in patients diagnosed with GDM in the range from 10% to 
35%(16) and suggested type I nature of the disease. But later studies showed that specific 
monoclonal antibodies against beta cells of pancreas among GDM patients are very less in 
the range of 1 to 2%(17) and demonstrated the type II nature of the disease thereby proving 
Source: ajpendo. physiology .org 
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that GDM was not due to antibody mediated (Type I) diabetes. Studies done among 
postpartum women who had GDM have also demonstrated defects in insulin sensitivity 
and insulin secretory response which suggested (Type II) nature of the disease (17). Thus 
among the women who have a genetic predisposition the metabolic stress of pregnancy 
would lead to GDM. 
4.6 Diagnosis of GDM over the years: 
Initially hyperglycaemia was detected in pregnancy and its adverse pregnancy outcomes 
was published in 1960s and the diagnostic criteria of 3 hr 100 grams glucose test was 
validated and accepted (18-20). 
Table: 4.1: Most commonly used guidelines for Diagnosis of GDM   
Organization Fasting 
Plasma 
Glucose 
Glucose 
Challenge 
1 hrs. plasma 
glucose 
2 hrs. 
plasma 
glucose 
3 hrs. 
plasma 
glucose 
WHO 1999* ≥ 7.0 mmol/l 75 g OGTT Not required ≥ 7.8 
mmol/l 
Not required 
ACOG** ≥ 5.3 mmol/l 100g OGTT ≥ 10.0 mmol/l ≥ 8.6 
mmol/l 
≥ 7.8 
Canadian Diabetes 
Association*** 
≥5.3 mmol/l 75 g OGTT ≥ 10.6 mmol/l ≥ 8.9 
mmol/l 
Not required 
IADPSG**** ≥ 5.1 mmol/l 75 g OGTT ≥ 10.0 mmol/l ≥ 8.5 
mmol/l 
Not required 
 
*One value is sufficient for diagnosis 
**Two or more values are required for diagnosis 
***Two or more values required for diagnosis 
**** One value is sufficient for diagnosis 
 
Source :WHO/repository for information sharing /NMH/13.2 
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Over the period of years, 75 gram oral glucose tolerance test became the standard of 
practice to diagnose Diabetes Mellitus Type II. WHO adopted this criterion to diagnose 
GDM since 1999. The various guidelines used to diagnose GDM over the period of years 
are provided in Table 4.1 In 2008 before the publication of HAPO study results Canadian 
Diabetic Association recommended 2 hr-75 grams glucose to screen women in pregnancy 
for GDM (18). In 2011, the ACOG recommended a two-step process of GDM diagnosis. 
The first screening with 50 grams of glucose 1hr challenge test at 24 to 28 weeks and the 
women found to have abnormal glycemic levels to undergo the confirmatory 3 hr - 100 
grams OGTT at 24 to 28 weeks (19). 
 
4.7 The Hyperglycaemia and adverse pregnancy outcomes (HAPO) study: 
The HAPO multi-centric study was conducted across 10 countries and included 25,505 
pregnant women from 15 centres. The participants were administered 75-g oral glucose-
tolerance test between 24 to 32 weeks of gestation. The primary outcomes studied were 
birth weight above the 90th percentile for gestational age, primary caesarean delivery, 
clinically diagnosed neonatal hypoglycaemia, and cord-blood serum C-peptide level above 
the 90th percentile. Secondary outcomes studied included pre term delivery, shoulder 
dystocia, birth injury, need for intensive neonatal care, elevated billirubin levels and pre-
eclampsia (21). 
The HAPO study results published in 2008 showed that there was a positive and continuous 
association of maternal glucose levels below that diagnostic criterion of GDM, which were 
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in practice until that time. It also proved positive association between diabetes and 
increased birth weight and increased cord-blood serum C-peptide levels. 
For an increase in FBG (fasting blood glucose), 1 hr BG (blood glucose), 2 hr BG by one 
standard deviation the adjusted odds ratio for primary outcomes were calculated. It was 
found that for birth weight above 90th percentile the odds ratios were 1.38(95% CI: 1.32 
to 1.44), 1.46 (1.39 to 1.53), and 1.38 (1.32 to 1.44) respectively. The C peptide levels 
above 90th percentile had an odds ratio of 1.55 (95% CI: 1.47 to 1.64), 1.46 (95% CI: 1.38 
to 1.54), and 1.37 (95% CI: 1.30 to 1.44) respectively. The odds ratios for caesarean 
delivery were 1.11 (95% CI, 1.06 to 1.15), 1.10 (1.06 to 1.15), and 1.08 (1.03 to 1.12); and 
for neonatal hypoglycaemia, 1.08 (95% CI, 0.98 to 1.19), 1.13 (1.03 to 1.26), and 1.10 
(1.00 to 1.12) respectively (21). Significant associations observed for secondary outcomes 
were weaker. This study conclusively identified strong associations between maternal 
glucose levels and several perinatal outcomes. 
 
4.8 Diagnosis of GDM- current IADPSG criterion: 
Gestational Diabetes Mellitus is diagnosed by the International Association of 
Diabetic and Pregnancy Study Group (IADPSG) 2008 recommendations (22). 
The recommendations were drawn on the findings of the Hyperglycaemia and 
Adverse Pregnancy Outcomes-HAPO study (21) which is a multinational, 
multicultural ethnically diverse study which i s elaborately described above.  
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The guide line is to diagnose GDM according to Glycated haemoglobin 
(HbA1C) ≥6.5% or Fasting Blood Glucose (FBG) ≥5.9 mmol/dl or ≥92 mg/dl at 
first prenatal visit. If the FBG value is <92 mg/dl, then GTT is to be done at 24 
to 28 weeks of gestation to find whether the mother has turned to be having 
GDM later in pregnancy. The cut off va lues for diagnosis of GDM are ≥  
92/180/153 mg /dl or 5.1/10/8.5 mmol/dl in fasting, 1hour and 2 hours venous 
samples after oral administration of 75 grams of glucose respectively  (22).The 
recommended kits for OGTT are DCCT/UKPDS (DCCT-Diabetes control and 
complication trial assay, UKPDS-United kingdom Diabetes Study Assay).The 
following Figure 4.2 illustrates the diagnostic cut off used in IADPSG criteria.  
Figure: 4.3: IADPSG criteria for diagnosis of Gestational Diabetes Mellitus 
 
 4.7 GDM and fetal outcomes 
Source: American diabetic association/ Diabetes care journal/ March 2010 
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4.9 One step Vs two-step process of screening for GDM: 
One among various studies done to find the best approach to screen GDM after the HAPO 
study is a cohort study done in Women’s Ambulatory health services clinic at Hartford. 
This study screened 812 pregnant women at 24 to 28 weeks of pregnancy or GDM. The 
women who were screened with two steps (ACOG guidelines) process 7% were diagnosed 
to have GDM. Out of the women who underwent one step process of diagnosis of GDM 
11.7% were diagnosed to have GDM (23). The new IADPSG criteria based on HAPO picks 
up women with impaired glucose tolerance as evidenced by many studies. After follow up 
on neonatal outcomes this study concluded that there was no significant difference between 
both methods of screening on neonatal outcomes (p>0.05)  
Figure: 4.4 Study results of one step screening Vs two step screening on neonatal 
outcomes 
                                   
 
Source: clinical diabetes journal Oct 2014 
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4.10 Cost utility analyses of various methods of screening for GDM: 
There were relatively fewer studies for cost analyses of screening for GDM. One cost utility 
analyses done at United States of America (U.S.A) which took three methods of GDM 
screening. 
One is the two step 50 g glucose followed by 100 grams OGTT, second is the 75 g glucose 
one step screening, third is the 100 grams OGTT method. The previous studies published 
on GDM screening were used to generate the effectiveness model. Sensitivity and 
Specificity of the screening tests, Quality Adjusted Life Years (QALY) was considered as 
outcome measures. The 75 g OGTT had sensitivity of 80% and specificity of 86%. The 
100 g OGTT had sensitivity and specificity of 100%. 
After analysing direct costs, indirect costs the cost utility was analysed for 4% prevalence 
of GDM. The expected costs were $2836 for two step screening, $2874 for 100 g glucose, 
$ 2895 for 75 g OGTT and $ 2995 for no screening in the maternal model. The expected 
costs were $ 77 for two step screening, $ 89 for 100 g glucose OGTT, $ 91 for 75 g OGTT 
and $ 80 for no screening (24). 
The conclusion arrived was that two step screening was cost effective in U.S.A. It was also 
concluded that 100 g OGTT could be used to screen GDM in more prevalent populations 
like Hispanics. Although the cost utility analyses showed that two step method of screening 
was better the generalisability of the results was not mentioned in the study. 
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4.11 GDM and foetal outcomes: 
4.11.1 GDM and short term foetal outcomes: 
GDM can lead to Macrosomia, still births, pre-term births, early neonatal deaths 
in the foetus (25, 26). Macrosomia refers to large babies with birth weight of 
more than 4 kilograms. Studies have proved that the presence of high glycemic 
environment in uterus is responsible for Large for gestational age  (27). 
Macrosomia causes problems during perinatal period  and leads to difficult 
modes of delivery of the baby like caesarean section, forceps delivery (26, 27) 
which lead to external trauma. Babies born to mothers with GDM are prone to 
have hypoglycaemia in their early neonatal period.  
  
4.11.2 Pathophysiology of Macrosomia: 
Macrosomia means large babies weighing more than 4 kg at birth. Women with GDM have 
increased peripheral resistance to insulin and decreased sensitivity which is the more 
common pathophysiology apart from antibody mediated GDM. The Human chorionic 
somatotropin (HCS) is partly related to secretion of insulin in foetus and inhibition of 
peripheral uptake of glucose in the mother (28).Because of the raised glycemic levels in 
the maternal blood foetal pancreas gets stimulated and starts to secrete insulin after 11th or 
12th week of gestation. Since insulin is an anabolic hormone elevated insulin levels leads 
to large growth of the baby and macrosomia (29-31). 
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4.11.3 GDM and short term foetal outcomes – congenital anomalies: 
In a cohort study done for 15 years at the National Women’s Hospital, Auckland, 221 
women with Type I diabetes, 315 women with Type II diabetes prior to pregnancy and 
1822 women with gestational diabetes were followed up during pregnancy and also during 
their postpartum period. Out of the 1822 GDM women 13% had a positive OGTT after 
delivery. This study had mixed population of Europeans and people of Asian origin. 
All the pregnant underwent ultrasound at 16 to 20 weeks of gestation and newborns were 
examined after delivery for congenital anomalies (32). 
 In Type I diabetes women the incidence of major congenital anomalies was 5.9%, in Type 
II diabetes the incidence was 4.4% and 1.4% in women with GDM. The incidence of major 
congenital anomalies was 4.6% in newly recognized diabetes group which was similar to 
incidence seen in Type I diabetes and Type II diabetes group. The other women in the 
GDM group had incidence of major congenital anomalies lower than all the other groups 
with p value <0.001(32). From this study it could be concluded that newborns of Type I 
and Type II diabetic mothers have higher risk of major congenital anomalies. The 
newborns of GDM mothers carry a lower risk than Type I and Type II but higher risk than 
general population in the incidence of major congenital anomalies.   
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4.11.4 GDM and long term foetal outcomes: metabolic syndrome  
A cohort study was done at Rhode Island Hospital by following up children of mothers 
with GDM and mothers without GDM and children born large for gestational age (LGA) 
and appropriate for gestational age (AGA). The primary marker of metabolic syndrome 
like obesity, dyslipidemia, glucose intolerance and hypertension were considered as 
outcomes and were elicited at 6, 7, 9, 11 years. Presence of any two or more than two of 
the outcomes was considered as criteria for metabolic syndrome. It was found in the study 
that the prevalence of metabolic syndrome was 15% among children who were large for 
gestational age and had gestational diabetic mothers (LGA / GDM) (33). The other groups 
were AGA/GDM, LGA/control, and AGA/control. These groups had a prevalence of 
metabolic syndrome of 4.8% which was similar to the prevalence in general population. It 
was also found that exposure of foetus to maternal obesity was a strong predictor of risk of 
metabolic syndrome and LGA status (33). 
 
4.11.5 GDM and long term foetal outcomes: intelligence levels of offspring: 
A cohort study followed up the children of GDM mothers and intelligence of the children 
assessed through Bayley scale of infant development (BSID) and Stanford Binet 
intelligence scale. The Bayley scale was administered at the age of two and Stanford Binet 
scale at age of three, four and five. It was found from the study that the intelligence levels 
were inversely proportional to Beta hydroxy butrate levels and free fatty acid levels in third 
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trimester of pregnancy after correcting for women with pre gestational diabetes, gestational 
diabetes and no diabetes (34).  
Beta hydroxyl butrate is an organic compound generated from liver during fasting state. It 
is not a ketone but the levels increase during ketosis. Thus regardless of the type of diabetes 
what the women had, ketosis due to uncontrolled sugar or prolonged fasting stage could 
lead to decreased intelligence levels in the children born to women with high glycemic 
levels. 
4.12 GDM and Maternal outcomes 
4.12.1 GDM and short term maternal outcomes:  
GDM in pregnancy leads to maternal complications pa rticularly more during 
the perinatal period. The poor outcomes are abnormal mode of deliverie s (21).  
A retrospective cohort study done for seven years showed that mothers with 
GDM were at significantly increased risk of gestational hypertension adjusted 
OR: 1.26 (95% CI: 1.21–1.32), pre-eclampsia adjusted OR: 1.30 (95%CI: 1.20–
1.41), premature rupture of membranes adjusted OR: 1.13 (1.06–1.20), 
caesarean section adjusted OR: 1.13 (1.10–1.17), and preterm delivery adjusted 
OR: 1.13 (1.08–1.18) (3). 
 
4.12.2 GDM and Hypertension during pregnancy 
Hypertension during pregnancy also called as Gestational Hypertension was significantly 
associated with GDM in previous studies. A Japanese study was done on 2651 consecutive 
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pregnant women and GDM and hypertension was screened at 24 to 27 weeks of pregnancy. 
The GDM was screened using the two step method of 50 g glucose challenge followed by 
75 g 2 hr OGTT. It was found from the study that gestational hypertension among impaired 
glucose tolerant women was 5.8% and among GDM women was 8.2% and both were 
significantly greater than women without GDM (p value <0.01) (35). However the 
incidence of Gestational hypertension was 2.2% among impaired glucose tolerant women 
and 4.1% among GDM women and was not significantly different from women with 
normal glycemic levels. 
Another population study done in Australia showed that GDM was associated with 
hypertension during pregnancy after adjusting for all confounding factors with risk of OR 
1.69 (95 % CI : 1.4 to 1.9)(36).  
The relationship between hypertension/ pre-eclampsia and GDM was explored in an animal 
study which proved that placental growth factor was reduced in pre-eclampsia and was the 
cause of reduced proliferation of pancreatic beta cells which thereby led to GDM. Mice 
were injected with chemical substances which mimicked hypertension and pancreatic beta 
cell function was studied. There was a significant association between hypertension 
induced mice and reduced placental growth factor levels and. There was a reduced growth 
of beta cells of pancreas in mice which had reduced placental growth factor levels 
suggesting the association between hypertension and impaired beta cell function (37). 
Scientific studies have also proven than a reduced potassium level in early pregnancy was 
a protective factor against occurrence of GDM and preeclampsia. The potassium levels of 
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women in early pregnancy was checked and they were classified in to groups with 
potassium levels < 3.5 meq/l, 3.5 to 3.99 meq/l, 4 to 4.99 meq/l and >5 meq/l. It was found 
that the rates of pre-eclampsia were 0.4%, 0.9%, 1.3% and 1.5% among the groups 
respectively which showed the protective nature of the low potassium levels. Among the 
group which ha d potassium levels more than 5 meq/l the occurrence of both GDM and 
pre-eclampsia was significantly associate (p = 0.027) (38). 
 
4.12.3 GDM and Pre-eclampsia – Association with oxidative stress: 
The recent scientific studies had proven that markers of oxidative stress include 
prostaglandins and more specifically epimers of prostaglandins like 8 iso PGF2α are 
significant predictors of GDM and also hypertension during pregnancy. 
A study was done on women recruited to HAPO study to find the association between 8 
iso PGF2α and risk of developing GDM and hypertension. The blood samples were taken 
at fasting at the time of OGTT at 24 to 32 weeks and also once at 34 to 37 weeks. 
Significant correlations were observed between maternal fasting plasma 8 iso PGF2α and 
both fasting   r = 0.20 (p value < 0.001) and 2-hour r=0.39 (p value < 0.001) plasma glucose 
levels at the time of OGTT. Gestational hypertension/pre-eclampsia occurred in 17 (4.2%) 
women, and at the time of OGTT, they had significantly higher fasting plasma 8-isoPGF2α 
(p value < 0.001), urine 8-isoPGF2α (p value < 0.005) and urine 2,3-dinor 8-isoPGF2α to 
creatinine ratios (p value < 0.001), as well as higher MAP (p value < 0.001) than women 
who remained normotensive. At 34–37 weeks, only random plasma 8-isoPGF2α was 
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significantly higher (p value < 0.001) among the women with gestational hypertension/pre-
eclampsia (39). The study concluded that oxidative stress in early pregnancy was 
significantly associated with development of GDM and hypertension during pregnancy. 
                   
4.12.4 GDM and long term maternal outcomes: 
The postnatal complications for the mother who had GDM are minimal but long 
term complications like the risk of developing Diabetes Type II is high. The risk 
of developing diabetes was 6.9% at five years and 21.1% at ten years following 
the initial diagnosis of GDM (9, 10). Standard care of GDM management is to 
test the postnatal mother at 6weeks with OGTT to know whether the sugars have 
come down to normal levels. Because of the development of Diabetes Type II 
in future there is a marginal risk of developing CVD-Cardio vascular diseases 
in future (9). 
 
In a Meta-analysis done out of 28 studies which had follow up of GDM patients it was 
found that the cumulative incidence of Diabetes was 2.6% at 6 weeks post-partum to 70% 
in 28 yrs follow up(10). The cumulative incidence increased in the first five years after 
confinement in mixed study populations or those without white women. It was found in 
the Meta analysis that elevated fasting glucose was a risk factor associated with type II 
Diabetes in future. The explanation given by the authors is that the women with elevated 
fasting glucose carry with them the same level of insulin resistance and later develop type 
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II Diabetes.  In one cohort study 1822 GDM women were followed up and 13 % of them 
had high glycemic levels six weeks after delivery and they were termed as ‘newly 
diagnosed Diabetes’ (32). 
 
4.13 Risk factors of GDM: 
4.13.1. Maternal obesity: 
A retrospective study showed that compared to normal weight, overweight women and 
obese women have greater risks of gestational diabetes mellitus with adjusted OR = 2.13 
(95% CI: 1.52 to 2.98) and adjusted OR = 2.85 (95% CI: 2.01 to 4.04) respectively. The 
adjusted odds for getting gestational hypertension was OR = 2.01 (95% CI: 1.27 to 3.19) 
and OR = 4.79 (95% CI: 3.13 to 7.32) and preeclampsia OR = 3.16 (95% CI: 1.12 to 8.91) 
and OR = 8.80 (95% CI: 3.46 to 22.40) respectively. The risk of oligo hydramnios in obese 
women is adjusted OR = 2.02 (95% CI: 1.25 to 3.27), polyhydramnios is OR = 1.76 (95% 
CI: 1.03 to 2.99), vaginal tears is OR = 1.24 (95% CI: 1.05 to 1.46). There was a lower risk 
of induced deliveries among obese women OR = 0.83 (95% CI: 0.72 to 0.95) (40). A Meta-
analysis done on 20 cohort studies published from 2001 to 2006 showed that the pre 
pregnancy BMI and risk of developing GDM are significantly associated. The unadjusted 
ORs of developing GDM were 2.14 (95% CI 1.82 to 2.53), 3.56 (3.05 to 4.21), and 8.56 
(5.07-16.04) among overweight, obese, and severely obese women compared with normal-
weight pregnant women, respectively (41).  
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4.13.1.2 Relationship between body fat and GDM: 
In a cohort study done on multi ethnic population at Oslo University, the association 
between weight gain, fat in trunk of the body, skin fold thickness and GDM were explored. 
The study took IADPSG criteria for diagnoses of GDM. The number screened was 728 and 
height, weight gain, fat and skin fold thickness was measured for all the pregnant women 
screened. The measurements were done at 15 weeks and 28 weeks. The objective was to 
find whether increase in the indicators of obesity like fat mass, skin fold thickness was 
associated with GDM. It was found that weekly increase in truncal body fat of 0.14 kg was 
associated with occurrence of GDM with adjusted OR of 1.31 (95% CI: 1.10 to 
1.56).increased weight gain was associated with GDM with adjusted OR 1.23 (95% CI: 
1.04 to 1.46)(42). It was also found that the skin fold thicknesses of South Asian  and east 
Asian population was more when compared with Europeans, Middle East and African 
population.   
In this study after adjustment for pre pregnancy BMI, truncal fat  it was found that south 
Asians have 5.9 times risk of having GDM (95% CI: 3.5 to 10.0) than Europeans who have 
2.1 times risk of having GDM (95% CI: 1.6 to 2.8)(42). It was concluded from the study 
to discourage South Asians from excess weight gain during pregnancy. 
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Figure: 4.5 Impact of excess body fat on pregnancy outcomes 
                                              
 
 
4.13.1.3 Measurement of obesity by body fat estimation in pregnancy: 
Studies have standardized the skin fold thickness measurement of biceps, triceps, sub 
scapular and mid arm circumference for calculating the body fat percentage and can be 
reliably used in research (43) for estimating BMI. The standard methods of body fat 
Source: Nature Reviews 
Endocrinology 8,     679-688 
(Nov 2012) 
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measurement methods like Dual energy X-ray absorptiometry, Magnetic Resonance 
Imaging (MRI) and Computed Tomography (CT) cause radiation to foetus and are not 
advised during pregnancy. The body fat can be calculated from various skin fold 
thicknesses by the following formula (43) given in Figure 4.4.  
Figure: 4.6: Formula for calculating Body Fat Percentage from Skin fold thickness  
 
   The percentage of essential body fat for women is greater than that for men, as a resource 
for demands of child bearing and other hormonal functions. Body fat percentage of more 
than 30% for men and more than 25% for women is considered as obesity (44).The other 
standard measure of obesity measurement is by BMI estimation using Body Mass Index. 
It is calculated by weight in kilograms/ (height in meter2). The WHO had prescribed 
standard BMI cut offs to classify underweight, over weight and obesity. The WHO standard 
criterion to diagnose obesity is a BMI equal to or above 30 as shown in shown in Table 4.2 
(45). 
                                                                                                                                                                           
Body fat% = 12.7 + (0.457 x triceps SFT) + (0.352 x subscapular SFT) 
+ 0.103 x (Biceps SFT – 0.057) x height + (0.265 x MUAC) 
 
 
SFT – Skin fold thickness 
MUAC – Mid upper arm circumference 
 
    
Source: BMC Pregnancy and Childbirth 2013; kannieappan et al (personal 
communication, Timothy Olds, 15/09/12) 
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Table: 4.2: International Classification of Underweight, Overweight, 
Obesity according to Body Mass Index  
 
Classification Principal cut off points 
Under weight < 18.50 
Severe thinness <16.00 
Moderate thinness 16.00 – 16.99 
Mild thinness 17.00 – 18.49 
Normal range 18.50 – 24.99 
Overweight ≥ 25.00 
Pre obese 25.00 – 29.99 
Obese ≥ 30.00 
Obese class I 30.00 – 34.99 
Obese class II 35.00 – 39.99 
Obese class III ≥ 40 
Source: WHO: Technical report series: 894/ 1995 
Adapted from 1995/2000/2004 
 
4.13.2 Low levels of physical activity 
The studies of the effect of physical activity on GDM show it to be a significant protective 
factor. A study done in 1997 which measured physical activity during pregnancy in mean 
metabolic equivalent expenditures found that there was no significant risk reduction in 
GDM by doing vigorous activity or walking (46). A cohort study was done from subjects 
of project viva at Massachusetts with 1805 women. The Television viewing and physical 
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activity time of the women was assessed before and after pregnancy. Among them 17% of 
women developed GDM and 83% of women had normal glucose tolerance.  After 
adjustment for age, race or ethnicity, history of GDM, family history of diabetes, and pre 
pregnancy body mass index, it was found that the women who did vigorous physical 
activity in the year before pregnancy experienced a reduced risk of GDM OR 0.56 ( 95% 
CI: 0.33 to 0.95) and abnormal glucose tolerance OR 0.76 (95% CI 0.57 to 1.00) 
(47).Women who reported vigorous activity before pregnancy and light-to-moderate or 
vigorous activity during pregnancy appeared to have a lower risk of both GDM OR 0.49 
(95% CI 0.24 to 1.01) and abnormal glucose tolerance OR 0.70 (95% CI 0.49 to 1.01) 
compared with women reporting these activities in neither time period(47). Walking and 
total physical activity provided modest benefits. There was no association between 
television viewing before or during pregnancy with risk of GDM or abnormal glucose 
tolerance. This particular study was a cohort study and physical activity were measured 
before pregnancy and after pregnancy using the questionnaire PASE (Physical Activity 
Scale for Elderly) and all the recruited women were tested for GDM during pregnancy. 
This study showed that physical activity before and during pregnancy was a protective 
factor against GDM and abnormal glucose tolerance.  
A Meta-analysis on physical activity and GDM showed that pre pregnancy physical 
activity, physical activity during pregnancy had the pooled odds ratio of 0.45 (95% CI: 
0.28 to 0.75) between the higher and lower categories. It also showed that early pregnancy 
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physical activity was protective against GDM with odds ratio 0.76 (95%CI: 0.70 to 0.83) 
(48). 
 
4.13.3 Family history of Diabetes Mellitus: 
The Framingham Offspring Study, a prospective epidemiologic study of over 5,000 young 
adults in the USA, reported that an individual who had one or both parents with Type II 
DM has a lifetime risk of 30–40% and 70% for developing diabetes respectively 
(49).Paternal history of diabetes was not found to be significantly associated with 
occurrence of Diabetes Mellitus (8) (49). 
Gestational diabetes mellitus is associated with family history of Diabetes. Many 
Retrospective and prospective studies eliciting history of diabetes among first degree 
relatives show that paternal history of diabetes to be significantly associated with 
occurrence of GDM RR 3.3 (95% CI:1.1 to 10.2),maternal history to be significantly 
associated with occurrence of GDM RR 3 (95% CI:1.2 to 7.3)(8).  
 
4.13.4 Age and Ethnicity: 
A population based cross sectional study done in Australia showed that the prevalence of 
GDM was 3.7% in women born in Australia and 11.5% in women of Asian origin. The 
prevalence in women born outside Australia is 41.4%. The study also found that except 
women born in north America all other had increased risk of developing GDM with age 
more than 30 (p<0.001)(25).  
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A population based cohort study done at Oslo University hospital among 759 multi ethnic 
women where OGTT was done on them. The South Asian women constituted 25%, Middle 
East women constituted 15%, others were Western European women in the study 
population. It was found that ethnicity was an independent factor in acquiring GDM. The 
South Asian women had OR 2.24 (95% CI: 1.26 to 3.97), Middle East women had OR 2.13 
(95% CI: 1.12 to 4.08) (50). 
A cohort study for Diabetes prevention program at George Washington University did a 
base line HbA1C level test for 3819 people more than 25 years of age. The results showed 
that the mean HbA1C levels among whites were 5.78%, among Hispanics 6%, among 
blacks 6.18%, American Indians 6.12% and 6% among Asians (51).  
 
4.13.5 Diet during pre-pregnancy: A cohort study was done using Nurses’ Health Study 
II and dietary intake was assessed periodically with semi quantitative food frequency 
questionnaire. The study was done to look for association between dietary calorie intake, 
glycemic load and incidence of GDM. It was found that dietary fibre had a continuous and 
inverse relationship with GDM. Every 10 gram / day increase in fibre per day led to 26% 
reduction in risk of GDM.  
The glycemic load in diet was positively related to GDM with 1.61 times higher than the 
lowest quintile (95% CI: 1.02 to 2.53, p value for trend 0.03). There was a risk of 2.15 
times in incidence of GDM on consuming low fibre and high glycemic diet (95% CI: 1.04 
to 4.29) (52). 
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4.13.6 Decreased sleep duration and risk of GDM: 
Recent evidences had shown that decreased sleep duration caused increased insulin 
resistance and decreased insulin sensitivity and are risk factors for GDM (53-55). 
A cohort study was done on women in early pregnancy to find the association between 
sleep hours and GDM. It was found that women who sleep less than or equal to four  hours 
are having  5.59 times (95% CI 1.31 to 23.69) risk of having GDM than those who sleep 
more than nine hours per night. The lean women with BMI less than 25 had RR 3.23 (95% 
CI 0.34 to 30.41), overweight women with BMI more than or equal to 25 had RR 9.83 
(95% CI 1.12 to 86.32) (54). 
Another study to find association between sleep and GDM showed that with every one 
hour of reduced sleep time was associated with 4% increase in glucose levels in blood. 
After adjustment for BMI it was found that disordered breathing during was associated 
with three times risk of acquiring GDM OR 3.0 (95 % CI: 1.2 TO 7.4) (55). Those who 
had short sleep had 3.4 times risk of GDM OR 3.4 (95% CI: 1.3 to 8.7) than those who had 
less than seven hours of sleep. The study also explored that frequent snoring during sleep 
was associated 3.4 times with GDM OR 3.4 (95% CI: 1.3 to 8.8) than those who did not 
snore (55). A prospective cohort study done on nulliparous women also explores significant 
association between snoring and GDM after adjusting for the confounding factors (53). 
The pathophysiology behind inverse relationship between sleep and GDM was first noted 
by Spiegel et al who found that the glucose tolerance, acute insulin response to glucose, 
effectiveness of glucose, sensitivity to insulin, disposition index are significantly differing 
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between sleep deprived population and reference population. It was found that the glucose 
tolerance levels among sleep deprived was 40% lower and insulin response to glucose was 
30% lower than the reference population (56). 
 
4.14 Effects of dietary interventions on outcomes of GDM: 
The interventions examined by various studies apart from pharmacological management 
are life style modification, dietary calorie/ carbohydrate restriction, physical activity etc. 
A Meta analyses was done on 1170 studies including 9 randomized controlled trials 
(RCT)which had interventions like life style modification, low glycemic index foods, low 
calorie food intake, low carbohydrate food intake on GDM women. It was found from the 
study that low glycemic index diet reduced percentage of women who used insulin with 
RR 0.76 (95% CI: 0.59 to 0.98) (57) when compared with women who were on controlled 
diet. There was a decrease in birth weight of newborns of mothers who consumed low 
glycemic diet with mean weight difference – 161.9g (95% CI: -246.4 to -77.4) (p < 0.001). 
There was no significant difference in maternal and newborn outcomes in women taking 
total calorie restriction and low carbohydrate diet (57). 
 
4.15 Effects of physical activity interventions on women with GDM: 
As discussed before there is an inverse association between high pre pregnancy physical 
activity levels and GDM (46, 47). Similarly physical activity had been proven to be 
decrease the risk of GDM during pregnancy if used as an intervention. Various studies 
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done with measurement of physical activity and GDM showed that physical activity was a 
protective against development of GDM. A Meta-analysis done on 469 studies, involved 
3401 participants which had physical activity apart from dietary restriction as intervention 
and development of GDM as outcomes. This Meta-analysis included only RCTs with 
pregnant women who did not have GDM at base line   
The effect of physical activity on GDM from the Meta analysis is illustrated by the 
following Figure 4.5 
Figure: 4.7: Forest Plot of Meta analyses on Physical activity and GDM    
   
Source: Ovid technologies Inc: Source ID 68771 
It was found that there was 28% reduction in risk of GDM in intervention group than 
control group and the RR was 0.72 (95% CI: 0.58 to 0.91) (58).  It was concluded from the 
analysis that physical activity provided a protective effect against development of GDM. 
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4.16 GDM model for prevention of Type II Diabetes Mellitus: 
 Among people with Type II Diabetes Mellitus 30% could be due to GDM during 
pregnancy. GDM is now being recognized as an opportunity to primarily prevent Type II 
DM and its complications. A new mathematical model has been developed which provides 
estimated costs of screening GDM and costs of lifestyle interventions to prevent GDM and 
compares the costs with the DALYs averted by not doing a universal screening. This model 
was tested in five countries including India. It was found that there was a net saving of $ 
78 per woman on performance of universal screening and post-partum lifestyle 
management which was lower on comparison to Israel. The DALY averted was 2.33 for 
India and the cost of averting one DALY was $11.32(59). It was concluded that the GDM 
model of universal screening for GDM and post-partum lifestyle management had a cost 
saving and good cost effectiveness ratio over no screening and no post-partum intervention.    
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5. Methodology 
5.1 Study setting: 
This study was carried out at the Rural Health Centre (CHAD Hospital) run by the 
Department of Community Health, Christian Medical College, Vellore. This hospital caters 
to health needs of Kaniyambadi block which has a population of 1, 20,000. Apart from 
Kaniyambadi block, people from neighboring towns of Ranipet, Arni and Polur come to 
CHAD hospital for health care. The hospital is located at a strategic location at Bagayam 
and is well connected by transport networks. 
5.2 Study period: 
The recruitment and patient home visits started in February 2015 and ended in July 2015. 
5.3 Sample size calculation: 
For estimate of prevalence of GDM, the sample size was calculated with the formula  
4 PQ/d2. 
The prevalence of GDM as obtained from various studies done in Tamilnadu varies 
between14% to 23%. Hence a prevalence of 15% was taken for calculating sample size. 
P=prevalence of GDM from previous studies, Q = (1-P), d = 20% relative precision.  
The sample size for estimating Gestational Diabetes was arrived as 
 4x15x85/3x3 = 567.  
Therefore n=567 antenatal women had to be screened for GDM with Oral Glucose 
Tolerance Test (OGTT) to estimate the Prevalence of GDM. 
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5.4 Inclusion criteria: 
All ante natal women attending the general ANC OPD of the Rural Health Centre (Ante 
Natal Care – Out Patient Department) irrespective of their obstetric score. 
5.5 Exclusion criteria: 
1. Women already known to have Diabetes Mellitus Type I and Type II. 
2. Women on drugs like steroids, olanzapine, phenytoin, thiazides. 
3. Women with auto immune diseases. 
5.6 Study design: 
The design used was a cross sectional study design. Antenatal women attending the 
Outpatient departments (OPD) for ante natal care between were recruited into the study 
after obtaining informed consent and were given a date for Oral Glucose Tolerance Test 
(OGTT). The women recruited into the study had varying gestational ages up to 28 
completed weeks. OGTTs were scheduled to be performed at the laboratory run by the 
CHAD Hospital between 24 to 28 weeks of gestational age. Detailed instructions regarding 
the test were given to the women at recruitment and also 2 days before scheduled testing 
through phone calls. 
5.7 Laboratory Diagnosis of GDM: 
The lab attached to the rural health centre is validated by Christian Medical College Quality 
control cell regularly. Blood glucose levels were analyzed by the GOD-POD method 
(Glucose Oxidase Peroxidase method).OGTT was performed with 75 grams of glucose 
dissolved in water and lime added to it for better taste. Blood samples were drawn at 
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fasting, 1 hrs. and 2 hrs. following oral glucose intake. Women who vomited after intake 
of 75 grams of glucose or at any time before the completion of the test were excluded. 
The total numbers of women recruited were 630. Out of 630 women recruited 51 women 
refused to participate in the study further, 16 were excluded due to vomiting and one subject 
had preterm labor before the scheduled date for OGTT. Finally 563 of the 630 antenatal 
women were screened for GDM with OGTTs. Among them 79 women were diagnosed to 
have GDM and 484 women had no GDM based on the IADPSG criteria.  
For studying the factors associated with GDM, all the79 women who were diagnosed to 
have GDM and a sub set of  158 women who did not have GDM were randomly selected 
for further home visits. The Principal Investigator was blinded to the GDM status of the 
selected subjects.  A total of 12 women (4 GDM and 8 Non GDM) refused further 
participation in the study. A total of 75 GDM and 150 women without GDM women were 
visited at their homes. Recruitment and follow up of subjects has been illustrated in Figure 
5.1. 
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Figure: 5.1: Flow chart depicting methodology of the study: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Total recruited at 
 CHAD Hospital = 630 
 
Women undergone  
OGTT = 563 
 
GDM = 79, 
Women without GDM = 484 
 
 
Refused OGTT=51 
Excluded 16 
(Reasons: vomiting,  
Preterm labor) 
 
All 79 GDM selected, 
158 women without GDM 
 selected randomly. 
    
   4 GDM women; 
8 women without 
GDM refused for 
further house visit 
75 GDM  
and 
150 women without GDM visited 
 
Questionnaire administered, 24 hrs dietary 
recalls done, Pregnancy physical activity 
(PPAQ) applied, Anthropometry measured. 
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5.8 Data collection: 
Subject identifiers including name, hospital number, date of birth, address and contact 
numbers were collected from the women who were recruited in the study. Informed consent 
was obtained for OGTT and home visit at the time of recruitment. The women were 
contacted before the home visits, their convenient date and time was collected and home 
visits were made. The women were visited within two weeks of OGTT. At the home visit, 
the study participant’s name, hospital number, address, obstetric details, family history of 
diabetes were collected and questionnaire on physical activity (PPAQ) administered. 
Dietary assessment was done using the 24 hour recall method.  
 
5.9 Study tool: 
A semi structured questionnaire was used to collect basic information of the study 
participant, obstetric details like last menstrual period, expected date of confinement, 
previous pregnancy details, previous delivery details, OGTT date, gestational age at OGTT 
and socio economic details like education, occupation, family income. For dietary 
assessment 24 hrs dietary recall method was used. The questionnaire also had components 
of body measurements like height, weight, biceps, triceps, subscapular skin fold 
thicknesses and mid upper arm circumference. 
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5.9.1 Assessment of dietary intake: 
The pregnant woman’s dietary intake was assessed by last 24 hour dietary recall method. 
The woman was asked about the food they consumed the previous day from morning to 
bed time. Standard cups, glasses, ladles, spoons were used to assess the actual amount of 
food consumed by the pregnant women. Then the calories present in the raw ingredients 
and food items were calculated using the database of “Nutritive Value of Indian Foods” by 
the National Institute of Nutrition (NIN) (60). The nutrients from the ready-made foods 
like biscuits and other packaged food items were calculated from the information given by 
the manufacturers. 
 
5.9.2 Assessment of physical activity: 
Physical activity levels during pregnancy were assessed by a semi quantitative 
questionnaire called Pregnancy Physical Activity Questionnaire  (PPAQ) (61). 
Two questions which were culturally not applicable were replaced by applicable 
ones with same intensity activity. It contains 32 questions each having five 
answer options. The questionnaire was translated into Tamil and back translated 
into English and validated. Participants had to respond the time spent on each 
activity. There were 13 questions on household/care giving activity, 5 on 
occupation activity, and 8 on sports/exercise activity, 3 on transportation 
activity and 3 on inactivity. The questionnaire was applied for the current 
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trimester of the pregnancy at the time of interview. Each question was read out 
to the patient in Tamil and the response was marked in the answer options.  
The answers had a fixed score which was multiplied with seven and again multiplied with 
intensity scores of that particular question to arrive at Metabolic Equivalents on Testing 
MET hrs/week for that particular question as per the coding guidelines provided in the tool. 
Then all the scores were added together to arrive at total activity in MET hrs per week. 
Finally, each woman in the study had scores for sedentary activity, light activity, moderate 
activity, vigorous activity, occupational activity and total activity in MET hrs per week. 
 
5.9.3Anthropometric measurements:  
The study participants height and weight were measured using a stadiometer and weighing 
scale. Height was measured to nearest centimeter and weight measured to nearest 100 
grams. Skin fold thickness measurement calipers was used to measure Biceps, Triceps, mid 
upper arm circumference to the nearest millimeters. Mid upper arm circumference was 
measured with a measuring tape in centimeters. All the measurements were taken twice 
and the mean of two readings was considered as the final measurement. 
 
5.9.3.1 Measurement of mid upper arm circumference: 
The mid upper arm circumference was measured with inch tape at the midpoint between 
head of the humerus and tip of the elbow. It was measure in centimeters and the 
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circumference was marked on the arm with a marker. The measurements were made twice 
and mean score was considered as final. 
 
5.9.3.2 Biceps skin fold thickness measurement: 
The biceps skin fold thickness was measured with the woman standing in a relaxed position 
with arms at sides. The site of measurement was identified on the anterior surface of the 
upper arm in line with the mid upper arm point and parallel to long axis. The thumb and 
index finger was used to grasp the skin fold and the skin was rolled from side to side to 
remove muscle. The skin fold thickness was measured with calibrated Harpenden’s 
calipers placed 90 degree to the skin, one centimeter distal to the marked site and the 
measurement taken after two seconds. The reading was measured in millimeters and 
average of the two readings was taken. 
 
5.9.3.3 Triceps skin fold thickness measurement: 
The triceps skin fold thickness was measured with the woman standing in relaxed position 
with arms at sides and at slightly pronated. The measurement was taken by standing behind 
her. The site of measurement was marked at the intersection of mid upper arm 
circumference line on the posterior surface of the arm. The thumb and index finger was 
used to grasp the skin fold and the skin was rolled from side to side to remove muscle. The 
skin fold thickness was measured with calibrated Harpenden’s calipers placed 90 degree 
to the skin, one centimeter distal to the marked site and the measurement taken after two 
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seconds. Biceps and triceps skin fold measurements were alternated to allow time for tissue 
decompression. Two readings were taken in millimeters and the average was considered. 
 
5.9.3.4 Sub scapular skin fold thickness measurement: 
The sub scapular skin fold thickness was measured by standing behind the woman. With 
the woman standing in a relaxed position and arms at her sides, the inferior angle of scapula 
was palpated. The site of measurement was 2cm and 45 degree inferior and oblique to the 
angle of scapula. The thumb and index finger was used to grasp the skin fold and the skin 
was rolled from side to side to remove muscle. The skin fold thickness was measured with 
calibrated Harpenden’s calipers placed 90 degree to the skin, one centimeter distal to the 
marked site and the measurement taken after two seconds. Two readings were taken in 
millimeters and the average was considered. 
The skin fold measurements were used to calculate the body fat percentage with the 
formula mentioned in Figure 4.3 (literature review section) 
The Body Mass Index (BMI) is given by weight in kilograms / (height in meters2) (45). 
The standard BMI cut off for obesity according to WHO guidelines is 30. As per the 
consensus statement, the BMI of more than 25 was taken as the cut off point for obesity 
for Indian populations (62). 
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5.9.4 Data entry and analysis:  
The data were entered into Epi data software version 3.1 and analysis done using SPSS 
software version 18.0.The demographic details and the descriptive statistics were 
calculated by using mean or median along with standard deviation. The study group was 
classified into GDM group and women without GDM according to the IADPSG criteria of 
diagnosis of Gestational diabetes mellitus. Descriptive analysis of study population on 
education, occupation, socio economic status, obstetric details was done. Bivariate analysis 
was done between associated factors like age, education, occupation, socio economic 
status, family history of Diabetes, physical activity, BMI, Body fat percentage between 
GDM and women without GDM. The mean differences between the groups were estimated 
by using chi square test of significance. Correlation was done between continuous variables 
and Pearson correlation co efficient estimated. Multivariate analysis by logistic regression 
was done with risk factors which proved to be significantly associated (p<0.05) with the 
outcome 
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6. Results 
6.1 Demographic characteristics of the study population: 
A total of 563 antenatal women attending antenatal OPD at CHAD Hospital were screened 
for GDM by OGTT. The age distribution of the study population is shown in the Figure 
6.1. 
Figure 6.1: Age distribution of study population 
 
The minimum age was 16 yrs. and maximum age was 38 yrs. The mean age of the screened 
population was 23.72 yrs; median was 23 yrs and standard deviation 3.84 yrs. 
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6.2. Prevalence of Gestational Diabetes mellitus among the study population: 
Figure 6.2: Prevalence of GDM among antenatal women: 
 
 
The prevalence of Gestational diabetes mellitus based on IADPSG criterion of OGTT 
≥92/180/153mg/dl among the study population of 563 was 14.0% (95% CI: 11.3% to 
16.7%). 
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6.3 Age specific prevalence of GDM among antenatal women: 
Figure: 6.3: Age specific prevalence of GDM among antenatal women 
 
 
An increasing prevalence of GDM with age was noted among the study participants. The 
age specific prevalence of GDM was found to be 9.6% among antenatal women less than 
or equal to 19 yrs of age (95% CI: 2.6% to 15.4%), 10.4% in age group 20 to 24 yrs (95% 
CI: 6.7% to 13.3%), 16.9% in age group 25 to 29 yrs (95% CI: 11% to 21%) and 31.5% in 
age group more than or equal to 30 years (18.9% to 43.1%). This increasing trend of 
prevalence with age was statistically significant (Chi square = 15.18; p<0.001).  
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6.4: Socio demographic characteristics: 
Table: 6.1: Socio demographic characteristics of study population 
 
In the GDM group, 25.3% had studied up to college level, 60% had studied up to higher 
secondary level of education, and 14.6% had studied up to high school. Among women 
without GDM, 18% had studied up to college level, 68.7% had studied up to higher 
secondary level and 13.3% up to high school level. There was no significant difference 
between both the groups in education levels (p value=0.680). In the GDM group 94.7% 
were house wives, 2.7% were doing clerical/agriculture/shop owning occupation and 2.6% 
 
 
GDM 
n=75 
NO GDM 
n=150 
p value 
Education 
level 
College 19(25.3%) 27(18%) 
0.680 Higher secondary 45(60%) 103(68.7%) 
Up to high school 11(14.6%) 20(13.3%) 
Occupation 
Housewife 71(94.7%) 141(94%) 
0.895 
Professional /semi 
professional 
0(0%) 4(2.6%) 
Clerical/agriculture/shop 
owning 
2(2.7%) 2(1.3%) 
Semiskilled/student 2(2.6%) 3(2%) 
Socio 
economic 
status 
High 20(26.6%) 26(17.3%) 
0.597 Middle 43(57.3%) 108(72%) 
Low 12(16%) 16(10.6%) 
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were either students or semi-skilled workers. There were no women in the professional, 
semiprofessional, skilled, unskilled occupation among the GDM group. Among the women 
without GDM 94% were house wives, 2.6% were professional or semiprofessionals, 1.3% 
were doing clerical/agriculture/shop owning occupation and2% were either college 
students or semi-skilled laborers. There were no skilled or unskilled laborers in the group. 
There was no significant difference in occupations between both the groups. The socio 
economic and education levels of the study population are illustrated in the Figure: 6.4 
Figure: 6.4: Socio economic status of the women with and without GDM: 
 
The GDM group had 26.6% women in high socio economic status, 57.3% in middle socio 
economic status and 16% in low socio economic status. The women without GDM had 
17.3% women in high socio economic status, 72% in middle socio economic status and 
10.6% in low socio economic status. There was no significant difference in socioeconomic 
levels between women with and without GDM shown in Figure 6.4 
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6.5 Antenatal characteristics of women with and without GDM:  
Table: 6.2: Antenatal characteristics of women with and without GDM 
  GDM n=75 
NO GDM 
n=150 
p value 
Gravida 
Primi gravida 34(45.3%) 74(49.3%) 
0.384 Gravida 2 26(34.7%) 50(33.3%) 
Gravida 3 and 
above 
15(20%) 26(17.33%) 
Parity 
Para 0 40(53.3%) 85(56.7%) 
0.417 Para 1 27(36%) 51(34%) 
Para 2 and above 8(10.6%) 14(9.3%) 
Previous preterm 
delivery(n=117)* 
yes 1(2.4%) 3(3.9%) 
0.672 
no 40 (97.6%) 73 (96.1%) 
Presence of bad 
obstetric** 
history(n=117)* 
Yes 3(7.3%) 3(3.9%) 
0.435 
no 38 (92.7%) 73 (96.1%) 
*includes women with second pregnancy and above only 
** Presence of stillbirths/intra uterine deaths/early neonatal death/congenital anomalies 
Among the women with GDM 45.3% were Primigravida, 34.7% were second gravida and 
20% were third gravida and above. Among women without GDM 49.3% were 
Primigravida, 33.3% were second gravida and 17.33% were third gravida and above. There 
was no significant difference between both the groups regarding present pregnancy status. 
Among the GDM group women 53.3% were nulliparous, 36% were primiparous and 10.6% 
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were multiparous and above. Among the women without GDM 56.7% were nulliparous, 
34% primiparous and 9.3% multiparous. Excluding the Primigravida women there were 
2.4% women with previous preterm delivery and 7.3% women with bad obstetric history 
(history of intra uterine death, still birth, early neonatal death, congenital anomaly) among 
GDM group women. There was no significant difference between both the groups with 
respect to previous preterm delivery (p value=0.672) or past bad obstetric history (p value= 
0.435).     
 
  6.6 Family history of Diabetes: 
Table: 6.3: Family history of Diabetes mellitus in women with and without GDM 
History of Diabetes 
mellitus(DM) 
 GDM(n=75) 
n (%) 
NO 
GDM(n=150) 
n (%) 
p value 
Maternal history of DM Yes 18 (24%) 10(6.7%) <0.001* 
No 57 (76%) 140 (93.3%) 
Paternal history of DM Yes 15(20%) 16(10.7%) 0.056 
No 60 (80%) 134 (89.3%) 
Any parent DM 
 
Yes 28(37.3%) 22(14.7%) <0.001* 
No 47 (62.7%) 128 (85.3%) 
Both parents DM 
 
Yes 5(6.7%) 4(2.7%) 0.150 
No  70 (93.3%) 146 (97.3%) 
*statistically significant 
In the GDM group 24% of women had maternal history of diabetes mellitus as compared 
to 6.7% among women without GDM. This difference was statistically significant by Chi-
square test for proportions (p value<0.001).There were 20% women with paternal history 
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of diabetes among women with GDM and 10.7% among women without GDM. . In the 
GDM group 37.3% women had at least one parent to be diabetic and among women without 
GDM 14.7% had at least one parent to be diabetic. 6.7% and 2.7% had history of diabetes 
in both parents among women with GDM and without GDM respectively. The GDM group 
had higher proportions of family history of diabetes than women without GDM. 
 
6.7 Nutritional anthropometry: 
Table: 6.4: Nutritional anthropometry of women with GDM and without GDM  
Anthropometry 
GDM 
(n=75) 
Mean(SD) 
NO GDM 
(n=150) 
Mean(SD) 
Mean 
difference 
‘t’ test 
value 
p value 
Height (cm) 
152.43(6.43) 154.10(5.72) 1.673 1.98 0.049 
Weight(kg) 
57.47(11.44) 53.07(10.63) 4.399 2.85 0.005* 
BMI 
24.70(4.44) 22.30(4.03) 2.401 4.069 <0.001* 
*statistically significant 
The anthropometric measurements taken include height, weight, biceps skin fold thickness, 
triceps skin fold thickness, subscapular skin fold thickness, mid upper arm circumference. 
The mean height in women of GDM group was 152.43 cm (SD 6.43) and the mean height 
among women without GDM was 154.10 cm (SD 5.72). There was no statistically 
significant difference between both the groups on student t test. The mean weight was 
57.47 kg (SD 11.44) in the GDM group and 53.07 kg (SD 10.63) among women without 
GDM and there was statistically significant difference (student t test p value <0.005). The 
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mean BMI in GDM group women was 24.70 (SD 4.44) and among women without GDM 
was 22.30 (SD 4.03). There was a statistically significant (student t test p value <0.001) as 
shown in Table 6.4.  
The mean Biceps skin fold thickness among GDM group was 11.99 (SD 5.56) and 9.78 
(SD 5.04) among women without GDM Table 6.5. There was a statistical significant 
difference between both the groups on ‘t’ test with p value 0.003. The mean of Triceps skin 
fold thickness among GDM group was 19.46 (SD 4.81) and 16.77 (SD 5.32) among women 
without GDM. There was statistically significant difference between both the groups on ‘t’ 
test with p value < 0.001. 
The mean Subscapular skin fold thickness among GDM group was 15.20 (SD 5.31) and 
13.34 (SD 4.66) among women without GDM. There was a statistically significant 
difference of means of both the groups on ‘t’ test with p value 0.008.The mean mid upper 
arm circumference among GDM group was 26.69 (SD 3.16) and 25.35 (SD 3.23) among 
women without GDM. There was a statistically significant difference of means of both the 
groups on ‘t’ test with p value 0.004.  
The mean body fat percentage of GDM group was 26.56 (SD 4.78) and 24(SD 4.74) among 
women without GDM. There was a statistically significant difference of means of both 
groups on ‘t’ test with p value <0.001. The significant differences between GDM group 
and women without GDM are given in the Table: 6.5 
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Table: 6.5: Skin Fold measurements of the study population 
*statistically significant 
6.8 Physical activity: 
The physical activity levels of GDM group and women without GDM were estimated in 
MET hrs per week based on PPAQ questionnaire. The physical activity done by the 
populations were grouped into different categories as performing sedentary activity, light 
activity, moderate activity, vigorous activity, household/care giving activity according to 
the intensity of the work done as per the PPAQ questionnaire. The mean MET hrs/wk. of 
moderate activity was 20.18 among GDM group and 24.23 among women without GDM. 
Except light activity all the other types of activities had the mean activity score more among 
women without GDM than GDM group meaning that women without GDM are physically 
more active than GDM group. 
Anthropometry GDM 
(n=75) 
Mean(SD) 
NO GDM 
(n=150) 
Mean(SD) 
Mean 
difference 
‘t’ test 
value 
p value 
Biceps skin fold 
thickness(mm) 
11.99(5.56) 9.78(5.04) 2.209 2.99 0.003* 
Triceps skin fold 
thickness( mm) 
19.46(4.81) 16.77(5.32) 2.686 3.68 <0.001* 
Subscapular skin 
fold thickness 
(mm) 
15.20(5.31) 13.34(4.66) 1.858 2.68 0.008* 
Mid upper arm 
circumference 
(cm) 
26.69(3.16) 25.35(3.23) 1.337 2.94 0.004* 
Body fat% 26.56(4.78) 24(4.74) 2.559 3.80 <0.001* 
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Table: 6.6: Physical activity pattern in women with and without GDM: 
Physical 
activity 
GDM 
(n=75) 
Mean(SD) 
NO GDM 
(n=150) 
Mean(SD) 
Mean 
difference 
‘t’ test 
value 
p value 
Sedentary 
activity 
(MET hrs/wk.) 
31.51(25.41) 35.01(27.08) 3.496 0.93 0.353 
Light activity 
(MET hrs/wk.) 
66.79(31.09) 62.79(27.12) 4.000 0.99 0.322 
Moderate 
activity 
(MET hrs/wk.) 
20.18(21.42) 24.23(25.93) 4.054 1.16 0.244 
Vigorous 
activity 
(MET hrs/wk.) 
2.07(5.20) 2.31(6.08) 0.240 0.29 0.770 
Household/care 
giving activity 
70.12(30.48) 73.44(35.80) 3.323 0.68 0.492 
Occupational 
activity 
(MET hrs/wk.) 
5.58(23.39) 7.15(25.55) 1.570 0.44 0.656 
Total activity 
(MET hrs/wk.) 
115.28(43.21) 118.83(43.21) 3.545 0.58 0.562 
 
 
On statistical analysis there was no significant difference between the mean activities of 
both the groups on ‘t’ test. 
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6.9 Correlation between skin fold thickness and BMI: 
Figure: 6.5 Correlation between BMI and skin fold thickness, mid upper arm 
circumference. 
 
58 
 
There was a positive significant correlation between skin fold thicknesses, mid upper arm 
circumference and BMI. The Pearson correlation co efficient was 0.59 (p value<0.0001) 
for Biceps skin fold thickness and BMI, 0.65 (p value<0.0001) for Triceps skin fold 
thickness, 0.69 (p value <0.0001) for subscapular skin fold thickness and BMI and 0.83 (p 
value <0.0001) for mid upper arm circumference and BMI. 
 
6.10 Correlation between body fat percentage and BMI: 
Figure: 6.6: Correlation between Body fat percentage and BMI 
 
The body fat percentage was calculated from the skin fold measurements using the formula 
given in Figure 4.3. The minimum body fat 15.5% and maximum was 39% and the mean 
body fat percentage among the study population was 24.8% and SD 4.90.The scatter plot 
representing body fat percentage in x axis and BMI in y axis is given by the figure 6.5. 
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There was a positive correlation between body fat percentage and BMI. The Pearson 
correlation co-efficient value was 0.78 (p value<0.001) and r2 = 0.621. 
 
6.11 Dietary calorie intake of women with and without GDM: 
Table: 6.7: Dietary energy intake of women with GDM and without GDM 
 
The mean dietary calorie intake of women with GDM and without GDM was 2042.30 and 
2323.63 respectively. The group without GDM on an average consumed an excess of 281 
kilo calories which was statistically significant as indicated by the ‘t’ test with 
 p value= 0.001 
 
 
 
 
 
 
24 hrs dietary 
recall 
GDM 
(n=75) 
Mean 
(SD) 
NO GDM 
(n=150) 
Mean 
(SD) 
Mean 
difference 
‘t’ test 
value 
p value 
Average 
Calorie 
intake/day 
2042.30 
(597.08) 
2323.63 
(626.24) 
281.33 3.22 0.001* 
*statistically significant 
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6.12 Factors associated with GDM: 
Table: 6.8: Association of Demographic factors with GDM 
  
GDM 
(n=75) 
n(%) 
No GDM 
(n=150) 
n(%) 
OR 
(95% CI) 
Chi 
square 
p value 
Age 
More than 23 yrs 
45 
(40.9%) 
65 
(59.1%) 1.96 
(1.11 to 
3.44) 
0.018* 
Less than 23 yrs 
30 
(26.1%) 
85 
(73.9%) 
Education 
 
Higher secondary 
and above 
64 
(33%) 
130 
(67%) 0.89 
(0.40 to 
1.98) 
0.78 
Higher secondary 
and below 
11 
(35.5%) 
20 
(64.5%) 
Occupation 
 
House wife 
71 
(33.5%) 
141 
(66.5%) 1.13 
(0.33 to 
3.80) 
0.84 
Employed 
4 
(30.8%) 
9 
(69.2%) 
Socio 
economic 
status 
 
High, Upper 
middle 
&Middle 
63 
(32%) 
134 
(68%) 0.62 
(0.28 to 
1.40) 
0.25 
Upper lower & 
lower 
12 
(42.9%) 
16 
(57.1%) 
*Statistically significant 
The associations of age, education, occupation and socio economic status were studied 
between GDM group and women without GDM by univariate analysis. The median age of 
women without GDM (23 yrs) was taken as cut off point to categorize age. The higher 
secondary education was taken as cut off point to classify education status. The socio 
economic classes of upper, upper middle and middle income groups were combined 
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together for classifying as high socio economic status. Among the socio demographic 
factors age was significantly associated with GDM OR 1.96 (95% CI: 1.11 to 3.44). The 
other factors like education had OR 0.89 (95% CI: 0.40 to 1.98), occupation had OR 1.13 
(95% CI: 0.33 to 3.80) and socio economic status had OR 0.62 (95% CI: 0.28 to 1.40) 
which were not significantly associated.  
 
6.13 Association of family history of Diabetes Mellitus and GDM: 
Table: 6.9: Family history of Diabetes Mellitus and GDM: 
Family history of 
Diabetes 
mellitus(DM) 
 
GDM 
(n=75) 
n (%) 
NO GDM 
(n=150) 
n(%) 
OR 
(95% CI) 
Chi square 
p value 
Maternal history 
of DM 
 
Yes 18(64.3%) 10(35.7%) 
4.42 
(1.92to10.16) 
<0.001* 
No 57(28.9%) 
140 
(71.1%) 
Paternal history 
of DM 
Yes 15(48.4%) 16(51.6%) 
2.09 
(0.97 to 4.51) 
0.056 
No 60(30.9%) 
134 
(69.1%) 
Any parent DM 
 
Yes 28(56%) 22(44%) 
3.46 
(1.80 to 6.64) 
<0.001* 
No 47(26.9%) 
128 
(73.1%) 
Both parents DM 
 
Yes 5(55.6%) 4(44.4%) 
2.60 
(0.67to10.01) 
0.150 
no 70(32.4%) 
146 
(67.6%) 
*statistically significant 
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The maternal history of Diabetes Mellitus was present in 64.3% of women in GDM group 
and 35.7 % among women without GDM. The odds of developing GDM among women 
with a maternal history of Diabetes Mellitus was 4.42 (95% CI: 1.92 to10.16) which was 
statistically significant (p<0.001). Paternal history of Diabetes Mellitus was present in 
48.4% of women in GDM group and 51.6% among women without GDM. The odds of 
developing GDM among women with paternal history of Diabetes Mellitus was 2.09 (95% 
CI: 0.97 TO 4.51) which was statistically not significant (p=0.056). History of diabetes in 
any one parent was present in 56% of women in GDM group and 44% among women 
without GDM. The odds of developing GDM if any one parent had history of Diabetes 
Mellitus was 3.46 (95% CI: 1.80 to 6.64) which was statistically significant (p<0.001). 
History of diabetes in both the parents was present in 55.6% women in GDM group and 
44.4% among women without GDM. The odds of developing GDM if history of Diabetes 
Mellitus was present in both the parents was 2.60 (95% CI: 0.67 to 10.01) which was 
statistically not significant (p=0.150). 
6.14 Association between antenatal factors and GDM 
The gravida score of two was taken as cut off to categorize pregnancy. Among women 
with gravida score of two and above 36.6% were in GDM group and 63.4% among women 
without GDM. There was no statistically significant association between Gravida and 
GDM as indicated by the OR 0.83 (95% CI: 0.41 to 1.70). Among women who had history 
of pre term delivery 25% were in GDM group and 75% among women without GDM. 
There was no statistically significant association between previous preterm delivery and 
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GDM as indicated by the OR 0.60 (95%CI: 0.61 to 6.04). The association of antenatal 
factors with GDM is given by Table: 6.10 
Table: 6.10 Association of Antenatal factors and GDM 
*includes women with second pregnancy and above only 
Among women who had bad obstetric history 50% were among GDM group and 50% 
among without GDM. There was no statistically significant association between bad 
obstetric history and GDM as indicated by the OR 1.92 (95% CI: 0.37 to 9.97).  
 
 
 
 
Antenatal factors  GDM 
(n=75) 
n (%) 
NO GDM 
(n=150) 
n (%) 
OR 
(95% CI) 
Chi 
square 
p value 
Gravida 
 
 
more than 
two 
15 
(36.6%) 
26 
(63.4%) 
0.83 
(0.41 to 1.70) 
0.625 
Less than or 
equal to two 
60 (32.6%) 124 (67.4%) 
Previous preterm 
delivery 
(n=117)* 
Yes 1(25%) 3(75%) 0.60 
(0.61 to 6.04) 
0.668 
No 74 (33.48%) 147(66.51%) 
Presence of bad 
obstetric 
history(n=117)* 
Yes 3(50%) 3(50%) 1.92 
(0.37 to 9.97) 
0.430 
No 72 (32.87%) 147(67.12%) 
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6.15 Association between anthropometric measurements and GDM: 
Table: 6.11: Association of various anthropometric measurements with GDM: 
Anthropometry  
GDM 
(n=75) 
n(%) 
NO GDM 
(n=150) 
n(%) 
OR 
(95% CI) 
Chi 
square 
p value 
Height 
 
Less than or 
equal to155 cm 
51 (34%) 99 (66%) 
1.09 
(0.60 to 1.97) 
0.764 
More than 155 
cm 
24 (32%) 51 (68%) 
Early 
pregnancy 
Weight 
More than 50 kg 48(39.3%) 74(60.7%) 
1.82 
(1.03 to 3.22) 
0.037* Less than or 
equal to 50 kg 
27(26.2%) 76(73.8%) 
Biceps SFT 
(Skin Fold 
Thickness) 
More than 8mm 52(41.9%) 72(58.1%) 
2.44 
(1.36 to 4.40) 
0.002* 
Less than or 
equal to 8 mm 
23(22.8%) 78(77.2%) 
Triceps SFT 
(Skin Fold 
Thickness) 
 
More than 16 mm 58(44.6%) 72(55.4%) 
3.69 
(1.97 to 6.92) 
<0.001* Less than or 
equal to16 mm 
17(17.9%) 78(82.1%) 
Subscapular 
SFT 
(Skin Fold 
Thickness) 
 
More than 
12.05mm 
50(40%) 75(60%) 
2.00 
(1.12 to 3.56) 
0.018* Less than or 
equal to 12.05 
mm 
25(25%) 75(75%) 
Mid upper arm 
circumference 
 
More than 25cm 47(42%) 65(58%) 
2.19 
(1.24 to 3.87) 
0.006* 
Less than or 
equal to 25 cm 
28(24.8%) 85(75.2%) 
*Statistically significant 
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The univariate analyses of various anthropometric measurements such as height, weight, 
biceps skin fold thickness, triceps skin fold thickness, subscapular skin fold thickness and 
mid upper arm circumference is presented in Table 6.11 
The median of women without GDM was used to categorize the anthropometric variables 
such as height, weight, biceps skin fold thickness, triceps skin fold thickness, sub scapular 
skin fold thickness and mid arm circumference. Among the women whose height was less 
than or equal to 155 cm 34% were in GDM group and 66% among women without GDM. 
The odds ratio OR was 1.09 (95% CI: 0.60 to 1.97) which was statistically not significant 
(p value=1.09). Among the women whose early pregnancy weight was more than 50 kg, 
39.3% were in GDM group and 60.7% among women without GDM. Early pregnancy 
weight more than 50 kg was significantly associated with GDM with an OR of 1.82 (95% 
CI: 1.03 to 3.22) which was statistically significant (p value=0.037).  
The women with biceps, triceps, and sub scapular skin fold thicknesses more than the cut 
off were 41.9%, 44.6%, 40% respectively in GDM group and 58.1%, 55.4%, 60% among 
women without GDM. The odds of developing GDM if biceps SFT more than 8 millimeter 
(mm) was 2.44(95% CI: 1.36 to 4.40) and was statistically significant (p=0.002), if triceps 
SFT more than 16 mm was 3.69(95% CI: 1.97 to 6.92) and was statistically significant 
(p<0.001), if sub scapular SFT more than 12.05 mm was 2.00(95% CI: 1.12 to 3.56) and 
was statistically significant (p=0.018). 
Among the women with mid upper arm circumference more than 25cm, 42% were in GDM 
group and 58% among women without GDM. The odds of developing GDM if mid upper 
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arm circumference more than 25 cm was 2.19 (95% CI: 1.24 to 3.87) which was statistically 
significant (p=0.006). 
 
6.16 Association between BMI, Body fat percentage and GDM: 
Table: 6.12: BMI, Body fat percentage and association with GDM: 
 
 
GDM 
n=75 
n(%) 
NO GDM 
n=150 
n(%) 
OR 
(95% CI) 
Chi 
square 
p value 
BMI 
More than 25 28(48.3%) 30(51.7%) 
2.38 
(1.28 to 4.41) 
0.005* 
Less than 25 47 (28.1%) 120 (71.9%) 
Body fat 
More than 23 % 60(43.5%) 78(56.5%) 
3.69 
(1.92 to 7.07) 
<0.001* 
Less than 23% 15 (17.2 %) 72 (82.8%) 
*Statistically significant 
The BMI cut off for Indians for obesity was considered more than 25 decided by the 
consensus statement (62). Among the women with BMI more than 25, 48.3% of women 
were in GDM group and 51.7% among women without GDM. The odds of developing 
GDM if early pregnancy BMI was more than 25 was 2.38 (95% CI: 1.28 to 4.41) and it 
was statistically significant (p value=0.005). 
The median of body fat percentage among women without GDM was 23% and it was taken 
as cut off for BMI categorization. Among the women with body fat percentage more than 
23percent, 43.5% were in GDM group and 56.5% among women without GDM. The odds 
67 
 
of developing GDM if body fat is more than 23 percent was 3.69 (95% CI: 1.92 to 7.07) 
which was statistically significant (p<0.001). 
 
6.17 Association between physical activity and GDM:  
Table: 6.13: Association between physical activity with GDM 
 
The recommended level of physical activity during pregnancy according to ACOG 
guidelines is moderate activity for 30 min for most of the days per week or 5 days/week. 
The score of moderate activity for 30 minutes per day is 0.25. The intensity ranges from 
≥3 to ≤6. The numbers of days of recommended physical activity are five days per week. 
Hence 0.25 x 6 x5 =7.5 MET hrs/week was the cut off used and physical activity less than 
7.5 MET hrs/week was considered as a factor to study association (63).  
Among the women who had physical activity less than 7.5 MET hrs/ week 36.5% were 
among GDM group and 63.5% were in NO GDM group. There was no significant 
association between low physical activity and GDM (p value =0.529). 
 
 
         Physical activity 
GDM 
n=75 
n(%) 
NO GDM 
n=150 
n(%) 
OR 
(95% CI) 
Chi 
square 
p value 
Moderate 
activity 
 
Less than or 
equal to 7.5 
MET hrs/week 
23(36.5%) 40 (63.5%) 
1.21 
(0.66 to 2.23) 
0.529 
More than 7.5 
MET hrs/week 
 
52(32.1%0 
110 
(67.9%) 
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6.18: Multivariate analysis to examine the association between potential risk 
factors and GDM: 
Table: 6.14: Multivariate analysis of the outcome GDM and its potential risk factors 
using binary logistic regression (Model 1: including Body fat %) 
*statistically significant 
A multivariate analysis using binary logistic regression was performed to look at the effect 
of age, history of diabetes in any parent, body fat percentage and physical activity on GDM. 
After adjusting for various confounding factors it was found that the odds of having GDM 
if any one parent had diabetes was 2.65 times than without a family history of GDM (p 
value =0.005). And the odds of having GDM if body fat percentage was more than 23% 
was 2.89 times than with less than 23% body fat ( p value =0.002). Both these associations 
were statistically significant as indicated by the 95% CI and p values. 
 
 Un adjusted 
OR(CI) 
Adjusted OR(CI) Adjusted p value 
Age more than 23 years 1.96 (1.11 to 3.44) 1.45(0.79 to2.65) 0.226 
Presence of DM in any 
parent 
3.46 (1.80 to 6.64) 2.65(1.34 to 5.25)* 0.005* 
Moderate Physical 
activity of ≤ 7.5 MET 
hrs/wk. 
1.21 (0.66 to 2.23) 1.18(0.61 to 2.26) 0.618 
Body fat more than 23 
percent 
3.69 (1.92 to 7.07) 2.89(1.47 to 5.68)* 0.002* 
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Table: 6.15: Multivariate analysis of the outcome GDM and its potential risk factors 
using binary logistic regression (Model 2: including BMI) 
*statistically significant 
 
A multivariate analysis using binary logistic regression was performed to look at the effect 
of age, history of diabetes in any parent, BMI and physical activity on GDM. After 
adjusting for the confounding factors it was found that the odds of having GDM if any one 
parent had history of diabetes was 2.91 times than without family history of DM 
 (p value 0.002). After adjusting for other variables BMI did not have any significant 
association with GDM. 
 
 
Un adjusted OR(CI) 
Adjusted OR(CI) Adjusted p value 
Age more than 23 years 1.96 (1.11 to 3.44) 
1.54(0.84 to 2.81) 0.155 
Presence of DM in any 
parent 
3.46 (1.80 to 6.64) 
2.91(1.48 to 5.72)* 0.002* 
Moderate Physical 
activity of 
≤7.5 MET hrs/wk. 
1.21 (0.66 to 2.23) 
1.18(0.89 to 3.36) 0.613 
BMI more than 25 2.38 (1.28 to 4.41) 1.73(0.61 to 2.25) 0.100 
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7. Discussion 
The prevalence of Gestational Diabetes in Tamil Nadu from a community based study in 
rural, semi urban, urban showed the prevalence to be 9.9%, 1.3.8% and 17.8% respectively 
(7). In an another study done at Trichirapalli, Tamilnadu the hospital based  prevalence of   
GDM was found out to be 23%.The study done at hospital Lucknow (6) had 41.9% 
prevalence of GDM which was high in comparison to previous studies done at Tamilnadu. 
The studies done at tertiary care centre in Haryana showed prevalence of 7.1% (5) which 
was less in comparison to  the prevalence in south India and Tamilnadu. 
In this present study, the prevalence of GDM among antenatal women attending a 
secondary level Rural Health Center in Vellore is 14%(11.3 to 16.7%) which is lower than 
the previously reported hospital based prevalence studies from Tamilnadu. The hospital 
based prevalence varies widely and one reason for that could be the different cut off values 
used to diagnose GDM. Ethnicity and diet factors could also play a role in the differing 
burden across regions. 
In the present study the age specific prevalence was 9.6% in women under 19 years 
of age, 10.4% in 20 to 24 years of age, 16.9% in 25 to 29 years of age, 31.5% in more than 
or equal to 30 years of age. It was found that as age advanced there was a trend of increasing 
prevalence of GDM. This finding is similar to other reported data from a Turkish study 
(64), the age wise prevalence in less than 25 years was 0.7%, 2.3% in 25 to29 years, 8.2% 
in 30 to 34 years and 9.5% in more than 35 years of age which also shows an increasing 
trend. Studies done in India and Tamilnadu also show similar trend of increasing 
71 
 
prevalence with age. The study done in Haryana showed that age of woman more than 25 
years is 3.8 times more than less than 25 years(5). In the community based study done in 
Tamilnadu age of woman more than 25 had adjusted odds ratio of 2.1(7) in the present 
study the age more than 23 years is significantly associated with GDM unadjusted OR 1.96 
(95% CI: 1.11 to 3.44). These results show that age is a significant factor associated with 
GDM. But on multivariate analysis after adjusting for confounders, the effect of age was 
not found to be significant.   
Most of the women in the present study were well educated. Among the women 
visited, 25.3% and 18% of women were educated up to college among women with GDM 
and without GDM respectively and 60% and 68.7% of women had up to higher secondary 
level of education in GDM group and among women without GDM respectively. GDM 
group had 14.6% of women who had equal to or less than high school level of education 
and women without GDM had 13.3% up to high school. There was no significant 
difference in education levels of both the groups which was similar to the Turkish study 
(64). On testing for association education was not significantly associated with GDM 
showing that education has no role in acquiring GDM. Universal education till high school 
in India and higher rates of schooling in Tamil Nadu could have contributed to this finding. 
The women in the study were house wives whose occupation involved home care, 
child care, cooking and other household activities. Among the GDM group 94.7% were 
housewives and 94% were house wives among women without GDM. Similarly in the 
Turkish study (64) 76.92% in the GDM group and 78.60% in among women without GDM 
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were house wives. There was no significant association between occupation and GDM. 
Most of the women attending CHAD hospital from upper lower to middle socio-economic 
strata and a majority of them are home makers. 
There were no women in class V (lower income) in Socio economic classification among 
the women visited. This could be because the rural health centre provided paid services for 
antenatal care and affordable families alone visit the centre. The socio economic status was 
not significantly associated with GDM. 
The studies done at Turkey (64) and Tamilnadu (65) showed 30.7% and 31.7% 
primi gravida among GDM women whereas in the present study there was 45.3% of primi 
gravida among GDM women. But there was no significant association between gravida 
status and GDM. This could have occurred because of the smaller number of women with 
gravida 3 and above as in this region a two child family norm is mostly practiced. 
In the present study, maternal history of Diabetes was significantly 
associated with GDM with OR of 4.42 (95% CI: 1.92 to10.16) with p value 
<0.001and it was statistically significant. But the paternal history of Diabetes was 
not significantly associated with GDM with OR of 2.09 (95% CI: 0.97 to 4.51) and 
p value 0.056. The association of family history of Diabetes in any parent is 
(adjusted OR) 2.65 times than those without family history (95% CI: 1.34 to 5.25). 
This shows that the family history of diabetes has a significant association with 
GDM. The genetic causes are important risk factors attributing to GDM as discussed 
in section 4.5 confirming the results of previous studies (8, 50)    
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In the present study, maternal height had no significant difference between the GDM 
group and women without GDM. But early pregnancy weight had significant difference 
between both the groups (p value= 0.005). In a similar study conducted at Lucknow there 
was no significant difference in height but there was significant difference in weight 
between both the groups (p value= 0.01) and early pregnancy weight was found to be a 
significant factor associated with GDM with p value 0.037 and OR 1.82 (1.03 to 3.22) (6). 
The pre pregnancy weight has been shown to be significantly associated with Preeclampsia 
and GDM was proven by various studies done previously (66). During pregnancy, the BMI 
of the woman naturally increases due to maternal and fetal components and hence pre 
pregnancy BMI is considered more reliable indicator of obesity. In a retrospective cohort 
study done at Slovenia, the pre pregnancy BMI was obtained from the records and the 
gestational weight gain, pregnancy outcomes were observed (67). It was found that GDM 
was associated with higher pre pregnancy BMI 27±6.1 kg/m2 with p value <0.001 in 
singleton pregnancies. In the same study smaller changes in BMI was associated with 
GDM in twin pregnancies p value<0.001. But in the present study previous health records 
of BMI were not present and hence pre pregnancy body weight was substituted with early 
recorded weight during pregnancy. There was a significant difference between BMI of both 
the groups p value <0.001. The BMI calculated using the earliest recorded pregnancy 
weight had a significant association with GDM (p value= 0.005) and OR of 2.38(95%CI: 
1.28 to 4.41). But in multivariate analysis the BMI was not significantly associated. This 
could be because the early pregnancy height and weight was obtained from antenatal cards 
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of the women and the first measurements were taken at first antenatal visit which 
could have been at varying gestational ages. 
The physical activity during pregnancy was measured using the PPAQ. It 
was found that women without GDM were more physically active than GDM group 
in all types of activities other than light activity. However the mean difference of 
activity between both the groups was small t test value 0.58 (p value 0.562) and was 
not significant. This could be because that among all the women visited, majority 
were house wives and both the groups were doing similar level of activity. 
The total energy intake was calculated with 24 hrs dietary recall method. It 
was done to assess the current dietary practices between both the groups. It was 
found that the GDM group consumed around 280 calories less than the women 
without GDM and it was statistically significant p value <0.001. The study 
participants were visited within two weeks of the OGTT being performed. There is 
a possibility that the GDM mothers became aware of their GDM status either 
through follow up at CHAD Hospital or through testing by the Public Health system 
which could have influenced their behaviors. 
The body fat percentage was calculated using skin fold thickness from 
biceps, triceps, sub scapular and mid upper arm circumference (43). The body fat 
percentage was used as a substituent of BMI during pregnancy as the BMI during 
pregnancy is due to both maternal and fetal components. The median of women 
without GDM was taken as the cut off for to categorize body fat percentage. In the 
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present study the body fat percentage in GDM group was more than women without GDM 
by mean difference of 2.55% which was statistically significant (p value <0.001). The skin 
fold thicknesses had a positive correlation with BMI and all were statistically significant 
(Figure 6.4). Body fat percentage had a positive correlation with BMI with Pearson 
correlation co efficient 0.78 and (p value <0.001). On univariate analysis, body fat 
percentage was significantly associated with GDM unadjusted OR 3.69 (95% CI: 1.92 to 
7.07) (p value <0.001). In multivariate analysis after adjusting for age, family history and 
physical activity the body fat percentage was significantly associated with GDM adjusted 
OR 2.89 (95% CI:1.47 to 5.68). It has been shown in previous studies that increase in 
truncal body fat during pregnancy was associated with 1.31 times of developing GDM 
(95% CI: 1.10 to 1.56) and increased weight gain was associated with GDM with adjusted 
OR 1.23 (95% CI: 1.04 to 1.46) (42). 
 
After adjusting for potential confounding factors, multivariate logistic regression analyses 
showed that family history of DM among parents and excess body fat >23% were 
significantly associated with GDM. Since body fat and BMI are positively correlated BMI 
> 25, age, family history, physical activity were taken for analyses and body fat was 
excluded in model 2. It was found that early pregnancy BMI more than 25 was not 
significantly associated with GDM and family history of DM became more significant. 
Other factors like age more than 23 years and low physical activity were not significant.  
 
76 
 
 
                                          8. Limitations 
The study had a dropout rate of 8% and the main reasons being travel time, long distance 
and difficulty to undergo OGTT test with fasting. Around 2.5% of the recruited women 
had vomiting after administration of 75 g of glucose and had to be excluded from the study. 
The plan was to meet the participants at their home within one week after the GTT, but due 
to long distances participants were met within two to three weeks after the GTT which 
could have resulted in recall bias and possibility of behavioral change among women who 
were aware of their GDM status. 
 
Though the principal investigator was blinded to the GDM status of the women selected 
for home visits, a few women in the study came back the next day for results and those 
with GDM were managed according to standard management of care of the hospital. The 
standard management care included counseling about diet calorie restriction, issue of diet 
chart. This procedure could have altered the dietary habits when home visit was done. 
 
The early pregnancy height, weight information was taken from the antenatal cards of the 
women, which were at different gestational ages. The information could have been biased 
because of inter observer variability between the hospital staff who measured them and 
also the calibration of the instruments used. 
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9.  Summary and Conclusions 
1. The prevalence of Gestational Diabetes among pregnant women seeking antenatal 
care at the Rural Health Centre run by the Christian Medical College, Vellore was 
14% (95% CI: 11.3% to 16.7%). 
2. A significantly increasing prevalence of GDM with age was observed. The 
prevalence of GDM was found to be 9.6%, 10.4%, 16.9% and 31.5 % among women 
in age groups up to 19; 20 to 24; 25 to 29 and above 30 years respectively.  
3. There was a significant positive correlation between different skin fold thicknesses 
and BMI. 
4. There was a significant positive association between family history of Diabetes 
Mellitus and GDM. If any one of the parent of the pregnant woman have/had 
Diabetes Mellitus then there is 2.65 times risk of acquiring Diabetes during 
pregnancy than other women who don’t have a family history of Diabetes.  
5. There was no significant association between low levels of physical activity and 
GDM. Women who are physically less active don’t have any higher risk than 
physically more active women in acquiring GDM.  
6. There was a significant positive correlation between body fat percentage and GDM.   
 
 
 
78 
 
10. Recommendations 
1. In view of the prevalence of GDM to be 14%, universal screening of GDM among 
pregnant women attending CHAD Hospital is recommended. Cost effectiveness studies 
could be done to find out difference in costs of doing a one-step screening at 24 to 28 weeks 
or a two-step screening. 
2. In case of universal screening proving not to be cost effective, then apart from 
factors like family history of Diabetes, previous GDM, bad obstetric history used for 
selective screening early pregnancy; first visit BMI >25 or Body fat percentage >23% 
could be used as an additional criteria to screen for GDM. 
3. Health education sessions at the hospital to include messages on importance of 
screening for GDM, diet and physical activity during pregnancy and special counseling 
sessions for women with GDM during follow up later. 
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Annexure 2 
Department of Community Health  
Christian Medical College, Vellore 
 
Study title: Prevalence of Gestational Diabetes Mellitus among antenatal women 
attending secondary care hospital at Vellore. 
 
Study number: 
                                                           Participant Information sheet 
 
This is a request to participate in a study to assess the prevalence of Gestational Diabetes Mellitus 
(GDM) among pregnant women seeking care at CHAD hospital, Bagayam, Vellore. GDM is a 
condition of high blood glucose levels in pregnant women. High blood glucose levels during 
pregnancy can lead to complications like large baby, labor before term, excessive fluid in the uterus, 
still births etc. This study is to find out the prevalence of gestational diabetes pregnancy among 
pregnant patients attending this hospital and risk factors for GDM. 
 
If you give your willingness to participate in the study you would undergo a lab blood test called 
Glucose tolerance test (GTT). You would be given 75 g of glucose powder mixed with a glass of 
water and flavored with lemon juice to drink and your blood sample would be taken 3 times. The 
results of this test would be disclosed 1 week later. A doctor from CHAD hospital would be visiting 
you at house before disclosure of results. The doctor would be asking you questions related to 
study like age, number of children, family history of diabetes, socio economic status, food and diet. 
Your height, weight, skin fold thickness would be measured. This study duration is from December 
2014 to may 2015 only. 
 
You need not pay the cost of Glucose tolerance test. 
There are no major risks associated with this procedure. The injection for collecting blood may be 
painful. Drinking glucose solution may be slightly uncomfortable.  But there are no major proven 
risks associated with this procedure. There is no unforeseeable risk with this procedure. We do not 
expect any injury related to this study and hence will not be compensating you monetarily. 
If you are participating in the study you can know whether you have the condition of Gestational 
diabetes. If you have the condition you will be treated at CHAD hospital for the same. 
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The anticipated benefits to science and humankind from this study is certain management 
guidelines can be made regarding the management of patients having Gestational diabetes, 
preventive measures can be done. 
 The study results may be published in a medical journal but your name and personal identifiers 
will not be published. However your personal details may be reviewed by the people associated 
with the study without any additional permission. Please read the above information carefully and 
feel free to ask any questions you may have about this study and information given. You will be 
given a copy of this information sheet and you are given an opportunity to ask questions, and your 
questions will be answered. Your participation in this research study is voluntary. You are also free 
to withdraw from this at any time. Your withdrawal will not affect any of your treatment receive 
from our institution (CMC Vellore and CHAD hospital) 
 
Would you like to participate in the study?    Yes                     No 
           
Name of the participant:     Signature of the participant 
Place: 
Date: 
 
 
 
 
 
 
 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
If you have any questions about this research study or possibly, please feel free to contact: 
Dr.Geetha R  9865779707 or Dr.Venkata Raghava Mohan04162284436. 
email:drgeethar@cmcvellore.ac.in or Department of Community health, Christian Medical College, 
Vellore (tel: 0416-2284207) 
 
 
 
 
 
Thumb Impression 
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                                             Christian Medical College, Vellore 
Department of Community Health and Development 
                                                           Informed Consent Form 
 
Study title: Prevalence and Risk factors of Gestational Diabetes Mellitus among 
antenatal women attending a secondary care hospital in Vellore 
 
  Study number: ------------------- 
   Subject’s initials: -------------------------------                     Subject’s name----------------------- 
   Date of birth/Age----------------- 
                                                                                        (Subject) 
 
(i) I confirm that I have read and understood the information sheet dated-----------------------------
---for the above study and have had the opportunity to ask questions. 
(ii) I understand that my participation in the study is voluntary and that I am free to withdraw 
at any time, without giving any reason without my medical care and legal rights being affected. 
(iii)I understand that my blood sample would be collected for testing glucose levels and I would 
be visited at home by the investigator and measurements of my body would be undertaken. I 
am aware that questions would be asked regarding my health and well being 
(iv) I understand that the Ethics committee and regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access.  However, I understand that my identity will not be revealed in any information released 
to third parties or published. 
(v) I agree not to restrict the use of any data or results that arise from this study provided such 
a use is only for scientific purposes. 
(vi) I agree to participate in the above study. 
 
 
Signature (or Thumb impression) of the Subject:  
Date: _____/_____/______ 
Signatory’s Name: _________________________________          
 
Signature or thumb impression of witness --------------------------------- -------------------- date: -------
------ 
Annexure 3 
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Signature or thumb impression of witness --------------------------------- -------------------- date: -------
------ 
 
Signature of investigator----------------------------------------------- date: --------------------- 
If you have any questions about this research study, please contact Dr.Geetha R 9865779707 or 
my advisor, Dr. Venkata Raghava Mohan at 04162284436 Email: 
drgeethar@cmcvellore.ac.in or Department of Community health, Christian Medical 
College, Vellore (tel: 0416-2284207) 
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